1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Measurements of absolute CBFmax and rCBFmax in each type of pathologic tumor
Grade/Histology No. CBFmax (mL/100 g/min) rCBFmax Tumor Contralateral Grade II (n = 13) Astrocytoma 5 75.4 ± 10.2a,b 83.2 ± 3.90 0.91 ± 0.18c,d Oligoastrocytoma 4 74.8 ± 12.1a,b 93.2 ± 28.8 0.83 ± 0.16c,d Oligodendroglioma 4 109.8 ± 47.8e 80.0 ± 9.6 1.38 ± 0.59e,f Grade III (n = 17) Anaplastic astrocytoma 6 127.2 ± 84.8e 78.0 ± 23.6 1.51 ± 0.68e,f Anaplastic oligoastrocytoma 7 125.1 ± 71.9e 82.4 ± 8.9 1.54 ± 0.88e,f Anaplastic oligodendroglioma 4 212.5 ± 87.5 78.8 ± 16.6 2.75 ± 1.02 Grade IV (n = 28) Glioblastoma 28 171.5 ± 58.7 77.0 ± 10.9 2.25 ± 0.79